FORNITURA del farmaco ENHERTU*INF 1FL POLV 100 MG, principio attivo trastuzumab deruxtecan AIC: 049328014 Ditta Daiichi Sankyo Italia S.p.A., per 12 mesi Codice Pratica 070426ADas
TED · 809017-2026complawardedNo deadline given
Value
Estimated€571,139 · 571,138.6 EUR
Awarded€571,139 · 571,138.6 EUR
WinnerDaiichi Sankyo Italia S.p.A.
Who already wins at this buyer
Firms with recorded awards from Azienda Unità Sanitaria Locale Umbria n. 2 in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE S.P.A. - SOCIETA UNIPERSONALE | 1 | €348,215 | 2026-10-21 |
Full buyer profile: what Azienda Unità Sanitaria Locale Umbria n. 2 buys and who wins it →
CPV codes
33690000 Medical equipment & pharmaceuticalsDescription
FORNITURA del farmaco ENHERTU*INF 1FL POLV 100 MG, principio attivo trastuzumab deruxtecan AIC: 049328014 Ditta Daiichi Sankyo Italia S.p.A., per 12 mesi Codice Pratica 070426ADas